ecancer

PARP inhibitory velaparib trialled in BRCA1/2 breast cancer

Dr Heather Han - H. Lee Moffitt Cancer Center, Tampa, USA

13 Dec 2016

Matched mutations in the progression of metastatic breast cancer

Dr Ofir Cohen - Broad Institute of MIT and Harvard, Cambridge, USA

13 Dec 2016

Positive impact of specialised surgery in the fight against cancer

ESSO - SSO - BSSO

13 Dec 2016

Infographic: Addressing unmet needs in metastatic breast cancer

13 Dec 2016

The need to better understand pathways that drive ER＋ metastatic breast cancer

Dr Julie Gralow - University of Washington, Washington, USA

13 Dec 2016

The experience of NGOs in Mexican cancer control

Berthar Aguilar - Fundación Cimab, Mexico City, Mexico

12 Dec 2016

Breast cancer screening in the Philippines

Kara Alikpala - ICanServe Foundation, Manila, Philippines

12 Dec 2016

Expert discussion on CDK 4/6 inhibition in breast cancer

Prof Richard Finn, Prof Michael Gnant, Dr Mark Harries and Prof Sandra Swain

12 Dec 2016

PD-1 therapy with eribulin for triple negative MBC

Dr Sara Tolaney - Dana–Farber Cancer Institute, Boston, USA

9 Dec 2016

Women experiencing menopause symptoms less likely to adhere to medication

Dr Samuel Smith - University of Leeds, Leeds, UK

9 Dec 2016

Breast cancer mortality declining globally

Dr Cécile Pizot - International Prevention Research Institute, Lyon, France

9 Dec 2016

Everolimus extends PFS for HR positive, HER2 negative breast cancer

Dr Noah Kornblum - Montefiore Medical Center, New York, USA

9 Dec 2016

More from ecancer